NEW YORK (GenomeWeb News) – Metabolon and Stemina Biomarker Discovery today announced they have settled their patent infringement dispute and reached a licensing agreement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.